Note on labeling: the events below come from r/peptides, r/PeptideTherapy, and other community sources for research-peptide and compounded tesamorelin use
Disclosures: Edward Walker, PhD, has the following relevant relationships to disclose: he has received research grant support from Calocurb
In particular, a prominent regulatory role of protein persulfidation seems apparent, perhaps because sulfide produced by this pathway may react with oxidized thiol groups
[31] provide an overview of pathways involving hypothalamic satiety signaling, ghrelin suppression, and improved insulin and lipid metabolism
GLP-1 receptor agonists and related incretin therapies absolutely have a known pancreatic signal in post-marketing surveillance and case reports
GLP-1R/GIPR AgonIST-1 is a double- receptor agonist for GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulin releasing peptide)